Single Cell Analysis Market Year 2022-31 | Danaher, Becton, Merck KGAA, QIAGEN N.V., Illumina, BGI Genomics, 10x Genomics, Dolomite Bio

Allied Market Research published a report, titled, "Single Cell Analysis Market By Product (Consumables, Instruments), By Techniques (Flow Cytometry, Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Mass Spectrometry, Others), By End User (Academic and Research Laboratories, Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostic Laboratories, Others), By Application (Oncology, Immunology, Neurology, Stem cell, Non-Invasive Prenatal Diagnosis, In-Vitro Fertilization (IVF), Others): Global Opportunity Analysis and Industry Forecast, 2021-2031." According to the report, the global single cell analysis industry was estimated at $2.64 billion in 2021, and is anticipated to hit $13.62 billion by 2031, registering a CAGR of 17.8% from 2022 to 2031. The report offers an explicit analysis of the changing market trends, top segments, key investment pockets, value chain, competitive scenario, and regional landscape.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭- https://www.alliedmarketresearch.com/request-sample/6553

𝐊𝐞𝐲 𝐩𝐥𝐚𝐲𝐞𝐫𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲:

1. Danaher Corporation
2. Becton
3. Merck KGAA
4. QIAGEN N.V.
5. Illumina, Inc.
6. Thermo Fisher Scientific, Inc.
7. BGI Genomics Co.Ltd.
8. Dickinson and Company
9. Agilent Technologies, Inc.,
10. Sartorius AG
11. Takara Holdingsinc
12. Oxford Nanopore Technologies.
13. 10x Genomics
14. Bio-Rad Laboratories
15. Berkley Light INC.
16. Dolomite Bio
17. Standard Biotools
18. Diasorin Group

𝐃𝐫𝐢𝐯𝐞𝐫𝐬, 𝐫𝐞𝐬𝐭𝐫𝐚𝐢𝐧𝐭𝐬, 𝐚𝐧𝐝 𝐨𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬:

The global single cell analysis market is on the rise, driven by increasing demand for single cell analysis and high-end technological advancements. Coupled with surge in R&D activities in the pharmaceutical and biotechnology industries, the market is expected to grow even further. Increase in focus on personalized medicines and growing prevalence of cancer are some of the factors that have contributed to the growth of the market.However, high cost of single cell analysis products is a major restraint that is hindering the growth of the market. Nevertheless, high growth potential of single cell sequencing is projected to pave the way for lucrative growth opportunities in the industry.

𝐆𝐞𝐭 𝐝𝐞𝐭𝐚𝐢𝐥𝐞𝐝 𝐂𝐎𝐕𝐈𝐃-19 𝐢𝐦𝐩𝐚𝐜𝐭 𝐚𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝐨𝐧 𝐭𝐡𝐞 𝐒𝐢𝐧𝐠𝐥𝐞 𝐂𝐞𝐥𝐥 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: https://www.alliedmarketresearch.com/request-for-customization/6553?reqfor=covid

𝐓𝐡𝐞 𝐜𝐨𝐧𝐬𝐮𝐦𝐚𝐛𝐥𝐞𝐬 𝐬𝐞𝐠𝐦𝐞𝐧𝐭 𝐭𝐨 𝐝𝐨𝐦𝐢𝐧𝐚𝐭𝐞 𝐛𝐲 2031:

According to a report by MarketsandMarkets, the global single cell analysis market is expected to reach $5.8 billion by 2031, growing at a CAGR of 17.9% from 2022 to 2031. The consumables segment is expected to account for the largest share of the market, with around two-thirds of the total market share in 2021. This is due to the high usability of products, frequent purchase of reagents, increase in prevalence of target diseases, and constant need for consumables required for assay.

𝐓𝐡𝐞 𝐨𝐧𝐜𝐨𝐥𝐨𝐠𝐲 𝐬𝐞𝐠𝐦𝐞𝐧𝐭 𝐭𝐨 𝐫𝐮𝐥𝐞 𝐭𝐡𝐞 𝐫𝐨𝐨𝐬𝐭:

The global single cell analysis market is expected to reach USD 9.31 billion by 2031, growing at a CAGR of 14.2% during the forecast period (2021-2031). By application, the oncology segment garnered more than one-third of the market share in 2021 and is expected to retain its dominance by 2031. The fact that single cell analysis has proven to be highly effective for prior diagnostics of cancer cells drives the segment growth. The neurology segment, on the other hand, is expected to exhibit the fastest CAGR of 18.8% from 2022 to 2031. This is attributed to increase in the prevalence of neurological disorders.In terms of region, North America held a dominant position in the global single cell analysis market in 2020 with a share of around 40%. This can be attributed to well-established healthcare infrastructure and government support for R&D activities in this region. Additionally, rising prevalence of chronic diseases and increasing demand for personalized medicine are also some of the key factors driving market growth in North America.

𝐍𝐨𝐫𝐭𝐡 𝐀𝐦𝐞𝐫𝐢𝐜𝐚 𝐠𝐚𝐫𝐧𝐞𝐫𝐞𝐝 𝐭𝐡𝐞 𝐦𝐚𝐣𝐨𝐫 𝐬𝐡𝐚𝐫𝐞 𝐢𝐧 2021:

Based on location, North the united states held the primary percentage in 2021, generating almost half of the worldwide unmarried mobile evaluation marketplace. Upward thrust inside the properly-established healthcare device, surge in range of geriatric patients, and supportive compensation policies in the healthcare gadget propel the marketplace boom. Europe, then again, might garner the quickest CAGR of 21.6% with the aid of 2031. Growth in incidences of most cancers and a spike in government funding for unmarried mobile analysis studies gas the marketplace increase. The other provinces analyzed throughout the record include Asia-Pacific and LAMEA.

𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲- https://www.alliedmarketresearch.com/purchase-enquiry/6553

𝐅𝐑𝐄𝐐𝐔𝐄𝐍𝐓𝐋𝐘 𝐀𝐒𝐊𝐄𝐃 𝐐𝐔𝐄𝐒𝐓𝐈𝐎𝐍𝐒?
Q1. What is the total market value of Single cell Analysis Market report ?
Q2. What would be forecast period in the market report?
Q3. Which is base year calculated in the Single cell Analysis Market report?
Q4. Which are the top companies hold the market share in single cell analysis market?
Q5. Which is the most influencing segment growing in the Single cell Analysis Market report?
Q6. What are the key trends in the Single cell Analysis Market report?
Q7. What is single cell analysis?

𝐎𝐟𝐟𝐢𝐜𝐢𝐚𝐥 𝐏𝐫𝐞𝐬𝐬 𝐑𝐞𝐥𝐞𝐚𝐬𝐞: https://www.alliedmarketresearch.com/press-release/single-cell-analysis-market.html

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of ""Market Research Reports"" and ""Business Intelligence Solutions."" AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa

Portland, OR, United States

USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141

UK: +44-845-528-1300

Hong Kong: +852-301-84916

India (Pune): +91-20-66346060

Fax: +1(855)550-5975

help@alliedmarketresearch.com

Web: https://www.alliedmarketresearch.com

Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research

This release was published on openPR.